1. What is the projected Compound Annual Growth Rate (CAGR) of the Psoriasis Treatment Market?
The projected CAGR is approximately 8.8%.
Psoriasis Treatment MarketPsoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033
Psoriasis Treatment Market by Drug Class (TNF Inhibitors, Interleukins Inhibitors, Others), by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), by Product Type (Biologics, Non-Biologics), by Route of Administration (Oral, Parenteral/Systemic, Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by North America (U.S., Canada), by Europe (U.K., Germany, France, Italy, Spain, Scandinavia, Rest of Europe), by Asia Pacific (Japan, China, India, Australia & New Zealand, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Rest of Latin America), by Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa) Forecast 2025-2033
Base Year: 2024
150 Pages
Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033
Psoriasis Treatment Market Unlocking Growth Opportunities: Analysis and Forecast 2025-2033
Key Insights
The Psoriasis Treatment Marketsize was valued at USD 26.37 USD billion in 2023 and is projected to reach USD 47.59 USD billion by 2032, exhibiting a CAGR of 8.8 % during the forecast period. Psoriasis is a medical condition that has a complex range of management options that are focused on the process of soothing the symptoms and healing the skin. Non systems including topical corticosteroids and vitamin D derivatives are typically employed to decrease inflammation and decrease the rate of cell proliferation. If patients undergo phototherapy under the direction of a doctor, the symptoms of the disease may improve for many patients. Organic treatments such as oral medications that include methotrexate and biological agents are employed to address severe cases as they affect the entire body because they act on the immune system of the body. Both treatment types can be significantly different regarding the impact of the treatment, for example, where topical treatments mainly affect one area of the body, biologic agents have a systemic effect on the body. The treatment offered to the patient is determined by the psoriasis severity and the effect that the treatment had on the individual to avoid or minimize the side effects and ensure that the treatment is consistent and effective with the purpose of offering the best quality health services with a positive impact on the patient’s quality of life.
Psoriasis Treatment Trends
- Increasing adoption of biologics and targeted therapies
- Growing preference for oral and topical medications
- Emphasis on personalized treatment plans
Driving Forces: What's Propelling the Psoriasis Treatment Market
- Increasing Prevalence: Escalating incidence of psoriasis attributed to genetic susceptibility, environmental influences, unhealthy lifestyle choices, and an aging population.
- Pharmaceutical Innovation: Advancements in drug therapy, including the development of highly effective biologics, targeted small molecules, and innovative delivery systems.
- Enhanced Awareness and Patient Empowerment: Government initiatives, advocacy groups, and patient support organizations play a crucial role in educating individuals about psoriasis, promoting self-management strategies, and empowering patients to advocate for their care.
- Governmental Support: Financial investments in research and clinical trials foster the development of novel and efficacious psoriasis treatments while ensuring patient access to affordable care.
- Emergence of Personalized Medicine: Advancements in genetic testing and biomarkers enable tailored treatment approaches based on an individual's unique disease characteristics, improving treatment outcomes and reducing adverse effects.
- Focus on Patient-Centric Care: The growing emphasis on patient-reported outcomes, shared decision-making, and telemedicine services enhance patient satisfaction, adherence to treatment, and overall health outcomes.
Challenges and Restraints in the Psoriasis Treatment Market
- High Cost of Treatments: Biologics and other advanced therapies can be expensive, limiting accessibility for some patients.
- Side Effects: Concerns about potential adverse effects associated with certain medications.
- Treatment Resistance: Some patients may develop resistance to existing therapies.
Emerging Trends in Psoriasis Treatment
- Precision Medicine: Tailoring treatments based on individual patient characteristics and genetic makeup.
- Digital Health: Use of mobile applications and telemedicine to improve patient engagement and treatment adherence.
- Combination Therapies: Combining different types of medications to enhance efficacy and reduce resistance.
Growth Catalysts in the Psoriasis Treatment Industry
- Government Initiatives: Support for clinical trials and research.
- Pharmaceutical Innovation: Continuous development of new and improved treatments.
- Patient Education: Programs to educate patients about psoriasis and its management.
Market Segmentation: Psoriasis Treatment Analysis
Drug Class:
- TNF Inhibitors
- Interleukins Inhibitors
- Others
Type:
- Plaque Psoriasis
- Psoriatic Arthritis
- Others
Route of Administration:
- Oral
- Parenteral/Systemic
- Topical
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Leading Players in the Psoriasis Treatment Market
- AbbVie Inc. (U.S.)
- Novartis AG (Switzerland)
- Johnson & Johnson Services, Inc. (U.S.)
- Pfizer Inc. (U.S.)
- LEO Pharma A/S (Denmark)
- Merck & Co., Inc. (U.S.)
- Amgen Inc. (U.S.)
- Eli Lilly and Company (U.S.)
- Evelo Biosciences, Inc. (U.S.)
- UCB S.A. (Belgium)
- Sun Pharmaceutical Industries Ltd. (India)
Significant Developments in the Psoriasis Treatment Sector
- September 2022: Bristol Myers Squibb received FDA approval for Sotyktu, an oral treatment for plaque psoriasis.
- July 2022: Health Canada accepted the New Drug Submission review for Roflumilast cream by Arcutis Biotherapeutics, Inc.
- January 2022: UCB S.A. received market authorization for Bimzelx from the Japanese MHLW.
- November 2021: AbbVie Inc. received EU approval for its SKYRIZI subcutaneous injection for psoriatic arthritis.
Comprehensive Coverage Psoriasis Treatment Market Report
The market report provides comprehensive coverage of the following aspects:
- Market size and growth projections
- Historical and forecast market data
- Competitive landscape and market share analysis
- Drivers, restraints, and industry trends
- Market segmentation by drug class, type, administration route, and distribution channel
- Company profiles of leading players
- SWOT analysis and strategies for growth
- Comprehensive industry analysis
Regional Insight
The report provides comprehensive insights into key regions, analyzing market size and growth prospects:
- North America: Leading the global market due to high disease prevalence and the presence of major pharmaceutical companies.
- Europe: Significant market due to well-established healthcare systems and a large patient population.
- Asia-Pacific: Growing market potential driven by rising disposable incomes, increasing urbanization, and improved access to healthcare services.
- Latin America: Emerging market with increasing awareness and expanding access to psoriasis treatments.
- Middle East and Africa: Region with untapped potential due to improving healthcare infrastructure and increasing awareness.
Segmentation
The report provides a detailed segmentation of the market, including:
- Drug class
- Type (Psoriatic Arthritis)
- Administration route
- Distribution channel
Patent/Trademark Analysis
The report provides an analysis of patents and trademarks related to psoriasis treatments.
Psoriasis Treatment Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 8.8% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Prevalence of Psoriasis to Boost Treatment Demand
- 3.3. Market Restrains
- 3.3.1. High Medication Costs to Restrict Market Growth in Emerging Countries
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Drug Class
- 5.1.1. TNF Inhibitors
- 5.1.2. Interleukins Inhibitors
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - by Type
- 5.2.1. Plaque Psoriasis
- 5.2.2. Psoriatic Arthritis
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - by Product Type
- 5.3.1. Biologics
- 5.3.2. Non-Biologics
- 5.4. Market Analysis, Insights and Forecast - by Route of Administration
- 5.4.1. Oral
- 5.4.2. Parenteral/Systemic
- 5.4.3. Topical
- 5.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.5.1. Hospital Pharmacies
- 5.5.2. Retail Pharmacies
- 5.5.3. Online Pharmacies
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
- 5.1. Market Analysis, Insights and Forecast - by Drug Class
- 6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Drug Class
- 6.1.1. TNF Inhibitors
- 6.1.2. Interleukins Inhibitors
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast - by Type
- 6.2.1. Plaque Psoriasis
- 6.2.2. Psoriatic Arthritis
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - by Product Type
- 6.3.1. Biologics
- 6.3.2. Non-Biologics
- 6.4. Market Analysis, Insights and Forecast - by Route of Administration
- 6.4.1. Oral
- 6.4.2. Parenteral/Systemic
- 6.4.3. Topical
- 6.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 6.5.1. Hospital Pharmacies
- 6.5.2. Retail Pharmacies
- 6.5.3. Online Pharmacies
- 6.1. Market Analysis, Insights and Forecast - by Drug Class
- 7. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Drug Class
- 7.1.1. TNF Inhibitors
- 7.1.2. Interleukins Inhibitors
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast - by Type
- 7.2.1. Plaque Psoriasis
- 7.2.2. Psoriatic Arthritis
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - by Product Type
- 7.3.1. Biologics
- 7.3.2. Non-Biologics
- 7.4. Market Analysis, Insights and Forecast - by Route of Administration
- 7.4.1. Oral
- 7.4.2. Parenteral/Systemic
- 7.4.3. Topical
- 7.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 7.5.1. Hospital Pharmacies
- 7.5.2. Retail Pharmacies
- 7.5.3. Online Pharmacies
- 7.1. Market Analysis, Insights and Forecast - by Drug Class
- 8. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Drug Class
- 8.1.1. TNF Inhibitors
- 8.1.2. Interleukins Inhibitors
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast - by Type
- 8.2.1. Plaque Psoriasis
- 8.2.2. Psoriatic Arthritis
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - by Product Type
- 8.3.1. Biologics
- 8.3.2. Non-Biologics
- 8.4. Market Analysis, Insights and Forecast - by Route of Administration
- 8.4.1. Oral
- 8.4.2. Parenteral/Systemic
- 8.4.3. Topical
- 8.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 8.5.1. Hospital Pharmacies
- 8.5.2. Retail Pharmacies
- 8.5.3. Online Pharmacies
- 8.1. Market Analysis, Insights and Forecast - by Drug Class
- 9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Drug Class
- 9.1.1. TNF Inhibitors
- 9.1.2. Interleukins Inhibitors
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast - by Type
- 9.2.1. Plaque Psoriasis
- 9.2.2. Psoriatic Arthritis
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - by Product Type
- 9.3.1. Biologics
- 9.3.2. Non-Biologics
- 9.4. Market Analysis, Insights and Forecast - by Route of Administration
- 9.4.1. Oral
- 9.4.2. Parenteral/Systemic
- 9.4.3. Topical
- 9.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 9.5.1. Hospital Pharmacies
- 9.5.2. Retail Pharmacies
- 9.5.3. Online Pharmacies
- 9.1. Market Analysis, Insights and Forecast - by Drug Class
- 10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Drug Class
- 10.1.1. TNF Inhibitors
- 10.1.2. Interleukins Inhibitors
- 10.1.3. Others
- 10.2. Market Analysis, Insights and Forecast - by Type
- 10.2.1. Plaque Psoriasis
- 10.2.2. Psoriatic Arthritis
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - by Product Type
- 10.3.1. Biologics
- 10.3.2. Non-Biologics
- 10.4. Market Analysis, Insights and Forecast - by Route of Administration
- 10.4.1. Oral
- 10.4.2. Parenteral/Systemic
- 10.4.3. Topical
- 10.5. Market Analysis, Insights and Forecast - by Distribution Channel
- 10.5.1. Hospital Pharmacies
- 10.5.2. Retail Pharmacies
- 10.5.3. Online Pharmacies
- 10.1. Market Analysis, Insights and Forecast - by Drug Class
- 11. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 UAE
- 12.1.2 South Africa
- 12.1.3 Saudi Arabia
- 12.1.4 Rest of Middle East Africa
- 13. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 South Korea
- 13.1.5 Taiwan
- 13.1.6 South East Asia
- 13.1.7 Australia
- 13.1.8 Rest of Asia-Pacific
- 14. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 Germany
- 14.1.2 France
- 14.1.3 Italy
- 14.1.4 United Kingdom
- 14.1.5 Spain
- 14.1.6 Nordics
- 14.1.7 Benelux
- 14.1.8 Rest of Europe
- 15. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 AbbVie Inc. (U.S.)
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 Novartis AG (Switzerland)
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Johnson & Johnson Services Inc.(U.S.)
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Pfizer Inc. (U.S.)
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 LEO Pharma A/S (Denmark)
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Merck & Co. Inc. (U.S.)
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Amgen Inc. (U.S.)
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Eli Lilly and Company (U.S.)
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Evelo Biosciences Inc. (U.S.)
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 UCB S.A. (Belgium)
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.11 Sun Pharmaceutical Industries Ltd. (India)
- 16.2.11.1. Overview
- 16.2.11.2. Products
- 16.2.11.3. SWOT Analysis
- 16.2.11.4. Recent Developments
- 16.2.11.5. Financials (Based on Availability)
- 16.2.1 AbbVie Inc. (U.S.)
List of Figures
- Figure 1: Global Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Region 2024 & 2032
- Figure 2: North America Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 3: North America Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 4: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 5: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 6: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 7: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 8: Europe Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 9: Europe Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 10: Latin America Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 11: Latin America Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 12: North America Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2024 & 2032
- Figure 13: North America Psoriasis Treatment Market Revenue Share (%), by Drug Class 2024 & 2032
- Figure 14: North America Psoriasis Treatment Market Revenue (USD billion), by Type 2024 & 2032
- Figure 15: North America Psoriasis Treatment Market Revenue Share (%), by Type 2024 & 2032
- Figure 16: North America Psoriasis Treatment Market Revenue (USD billion), by Product Type 2024 & 2032
- Figure 17: North America Psoriasis Treatment Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 18: North America Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2024 & 2032
- Figure 19: North America Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 20: North America Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2024 & 2032
- Figure 21: North America Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 22: North America Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 23: North America Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 24: Europe Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2024 & 2032
- Figure 25: Europe Psoriasis Treatment Market Revenue Share (%), by Drug Class 2024 & 2032
- Figure 26: Europe Psoriasis Treatment Market Revenue (USD billion), by Type 2024 & 2032
- Figure 27: Europe Psoriasis Treatment Market Revenue Share (%), by Type 2024 & 2032
- Figure 28: Europe Psoriasis Treatment Market Revenue (USD billion), by Product Type 2024 & 2032
- Figure 29: Europe Psoriasis Treatment Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 30: Europe Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2024 & 2032
- Figure 31: Europe Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 32: Europe Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2024 & 2032
- Figure 33: Europe Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 34: Europe Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 35: Europe Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 36: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2024 & 2032
- Figure 37: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Drug Class 2024 & 2032
- Figure 38: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Type 2024 & 2032
- Figure 39: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Type 2024 & 2032
- Figure 40: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Product Type 2024 & 2032
- Figure 41: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 42: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2024 & 2032
- Figure 43: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 44: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2024 & 2032
- Figure 45: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 46: Asia Pacific Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 47: Asia Pacific Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 48: Latin America Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2024 & 2032
- Figure 49: Latin America Psoriasis Treatment Market Revenue Share (%), by Drug Class 2024 & 2032
- Figure 50: Latin America Psoriasis Treatment Market Revenue (USD billion), by Type 2024 & 2032
- Figure 51: Latin America Psoriasis Treatment Market Revenue Share (%), by Type 2024 & 2032
- Figure 52: Latin America Psoriasis Treatment Market Revenue (USD billion), by Product Type 2024 & 2032
- Figure 53: Latin America Psoriasis Treatment Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 54: Latin America Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2024 & 2032
- Figure 55: Latin America Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 56: Latin America Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2024 & 2032
- Figure 57: Latin America Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 58: Latin America Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 59: Latin America Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
- Figure 60: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Drug Class 2024 & 2032
- Figure 61: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Drug Class 2024 & 2032
- Figure 62: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Type 2024 & 2032
- Figure 63: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Type 2024 & 2032
- Figure 64: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Product Type 2024 & 2032
- Figure 65: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 66: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Route of Administration 2024 & 2032
- Figure 67: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Route of Administration 2024 & 2032
- Figure 68: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Distribution Channel 2024 & 2032
- Figure 69: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Distribution Channel 2024 & 2032
- Figure 70: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion), by Country 2024 & 2032
- Figure 71: Middle East & Africa Psoriasis Treatment Market Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Region 2019 & 2032
- Table 2: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 3: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 4: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 5: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 6: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 7: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Region 2019 & 2032
- Table 8: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 9: United States Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 10: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 11: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 12: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 13: UAE Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 14: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 15: Saudi Arabia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 16: Rest of Middle East Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 17: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 18: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 19: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 20: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 21: South Korea Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 22: Taiwan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 23: South East Asia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 24: Australia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 25: Rest of Asia-Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 26: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 27: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 28: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 29: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 30: United Kingdom Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 31: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 32: Nordics Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 33: Benelux Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 34: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 35: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 36: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 37: Argentina Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 38: Rest of South America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 39: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 40: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 41: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 42: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 43: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 44: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 45: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 46: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 47: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 48: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 49: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 50: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 51: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 52: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 53: U.K. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 54: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 55: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 56: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 57: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 58: Scandinavia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 59: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 60: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 61: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 62: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 63: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 64: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 65: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 66: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 67: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 68: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 69: Australia & New Zealand Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 70: Rest of Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 71: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 72: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 73: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 74: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 75: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 76: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 77: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 78: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 79: Rest of Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 80: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Drug Class 2019 & 2032
- Table 81: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Type 2019 & 2032
- Table 82: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Product Type 2019 & 2032
- Table 83: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Route of Administration 2019 & 2032
- Table 84: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Distribution Channel 2019 & 2032
- Table 85: Global Psoriasis Treatment Market Revenue USD billion Forecast, by Country 2019 & 2032
- Table 86: GCC Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 87: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
- Table 88: Rest of the Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Application 2019 & 2032
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.
Frequently Asked Questions
2. Which companies are prominent players in the Psoriasis Treatment Market?
Key companies in the market include AbbVie Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc.(U.S.), Pfizer Inc. (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc. (U.S.), Amgen Inc. (U.S.), Eli Lilly and Company (U.S.), Evelo Biosciences, Inc. (U.S.), UCB S.A. (Belgium), Sun Pharmaceutical Industries Ltd. (India).
3. What are the main segments of the Psoriasis Treatment Market?
The market segments include Drug Class, Type, Product Type, Route of Administration, Distribution Channel.
4. Can you provide details about the market size?
The market size is estimated to be USD 26.37 USD billion as of 2022.
5. What are some drivers contributing to market growth?
Growing Prevalence of Psoriasis to Boost Treatment Demand.
6. What are the notable trends driving market growth?
Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.
7. Are there any restraints impacting market growth?
High Medication Costs to Restrict Market Growth in Emerging Countries.
8. Can you provide examples of recent developments in the market?
September 2022 – Bristol Myers Squibb received the FDA approval for Sotyktu, an oral, allosteric tyrosine kinase 2-inhibitor for treating adults suffering from moderate-to-severe plaque psoriasis.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in USD billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Psoriasis Treatment Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Psoriasis Treatment Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Psoriasis Treatment Market?
To stay informed about further developments, trends, and reports in the Psoriasis Treatment Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.